Login to Your Account

How Much Is Genzyme Worth? Sanofi Bid Rumored at $18.7B

By Jennifer Boggs

Friday, July 30, 2010
Shares of Genzyme Corp. continued climbing Thursday amid rumblings of a possible $70-per-share bid from Sanofi-Aventis SA, but whether $18.7 billion is a fair takeout price for the Cambridge, Mass.-based biotech clearly remains up for debate. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription